Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
GRI Bio, Inc. (GRI) had Income from Continuous Operations of $-8.21M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-10.12M |
|
-- |
|
-- |
|
$8.23M |
|
$-8.23M |
|
$0.03M |
|
$-8.21M |
|
$-8.21M |
|
$-8.21M |
|
|
Income from Continuous Operations |
$-8.21M |
$-8.21M |
|
$-8.21M |
|
$-8.23M |
|
$-8.23M |
|
0.18M |
|
0.18M |
|
$-55.21 |
|
$-55.21 |
|
| Balance Sheet Financials | |
$5.62M |
|
$0.00M |
|
$0.12M |
|
$5.74M |
|
$1.64M |
|
-- |
|
$0.07M |
|
$1.71M |
|
$4.03M |
|
$4.03M |
|
$4.03M |
|
0.53M |
|
| Cash Flow Statement Financials | |
$-8.61M |
|
-- |
|
$11.83M |
|
$1.81M |
|
$5.03M |
|
$3.22M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-203.55% |
|
-203.55% |
|
-143.00% |
|
-203.55% |
|
$7.68 |
|
$-46.98 |
|
$-46.98 |
|